COLORADO SPRINGS, CO--(Marketwired - Mar 24, 2016) - Cannabis Science, Inc. (OTC PINK: CBIS), a U.S. company specializing in the development of cannabis-based medicines, today announced the Company has negotiated a major new drug development and facilities deal in the State of Nevada. The premises include an approximately 360,000 sq. ft. licensed cannabinoid grow and a separate formulation processing operation in Nevada. The transaction includes access to a separate educational and research facility for its drug development programs targeting critical ailment research initiatives.

https://finance.yahoo.com/news/cannabis-scien...56707.html